Market revenue in 2023 | USD 884.6 million |
Market revenue in 2030 | USD 3,446.4 million |
Growth rate | 21.4% (CAGR from 2023 to 2030) |
Largest segment | Genetic tests |
Fastest growing segment | Direct to Consumer Tests |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Genetic Tests, Direct to Consumer Tests, Esoteric Tests |
Key market players worldwide | Abbott Laboratories, Roche Holding AG, Siemens Healthineers AG ADR, Thermo Fisher Scientific Inc, BioMerieux SA, Becton Dickinson & Co, Danaher Corp, Qiagen NV, Hologic Inc, Agilent Technologies Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision diagnostics market will help companies and investors design strategic landscapes.
Genetic tests was the largest segment with a revenue share of 54.67% in 2023. Horizon Databook has segmented the Italy precision diagnostics market based on genetic tests, direct to consumer tests, esoteric tests covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy precision diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Italy precision diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account